Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Daniel Janney

Affiliations

  • Director at Krystal Biotech Inc. (KRYS), 2019-09-03
  • Director at Sutro Biopharma Inc. (STRO), 2019-06-19
  • Director at Allakos Inc. (ALLK), 2019-06-11
  • Director at Esperion Therapeutics Inc. (ESPR), 2019-05-31
  • Director at Viveve Medical Inc. (VIVE), 2019-01-02
  • Other at Neothetics Inc. (NEOT), 2015-12-30
  • Large Shareholder at Zs Pharma Inc. (ZSPH), 2015-06-09
  • Large Shareholder at Atyr Pharma Inc (LIFE), 2015-05-15
  • Large Shareholder at Carbylan Therapeutics Inc. (CBYL), 2015-04-14
  • Large Shareholder at Trevena Inc (TRVN), 2014-12-10
  • Large Shareholder at Applied Genetic Technologies Corp (AGTC), 2014-11-19
  • Large Shareholder at Immune Design Corp. (IMDZ), 2014-07-31
  • Large Shareholder at Aerie Pharmaceuticals Inc (AERI), 2014-07-18
  • Large Shareholder at Ellie Mae Inc (ELLI), 2011-04-21
  • Large Shareholder at Acelrx Pharmaceuticals Inc (ACRX), 2011-02-18
  • Large Shareholder, Director at Anesiva Inc. (ANSV), 2010-01-08
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ALLK $18.00 250,000 Large Shareholder, Director 11,519,200 2018-07-23 Filing
KRYS $10.00 200,000 Director 330,590 2017-09-22 Filing
VIVE $4.00 500,000 Director 1,381,955 2017-03-17 Filing
VIVMF $5.00 200,000 Director 881,954 2016-06-17 Filing
VIVMF $0.70 857,142 Large Shareholder, Director 5,455,632 2015-11-24 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KRYS $46.18 32,190 Director 366,362 2019-08-30 Filing
KRYS $47.50 700 Director 398,552 2019-08-29 Filing
KRYS $46.61 55,794 Director 399,252 2019-08-29 Filing
ESPR $48.19 700 Director 1,359,967 2017-03-21 Filing
ESPR $47.54 56,855 Director 1,360,667 2017-03-21 Filing